Spyre Therapeutics, Inc.

SYRE · XNAS

CIK 1636282fmd_0FA2NSSQYK2ZDY8GV9FJTWMSJVManufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jan 01, 2014 to Sep 30, 2026, 48 periods

Ratios computed from the standardized statements. Select a value to open its proof.